Evidence map›Paper›PMID 27044885›Full record

Trial reportBehavioural and cognitive psychotherapy2016

Targeting Recovery in Persistent Persecutory Delusions: A Proof of Principle Study of a New Translational Psychological Treatment (the Feeling Safe Programme).

Daniel Freeman, Jonathan Bradley, Felicity Waite, Bryony Sheaves, Natalie DeWeever, Emilie Bourke, Josephine McInerney, Nicole Evans, Emma Černis, Rachel Lister and 2 more

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in Behavioural and cognitive psychotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 4 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 4 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The revised GreenPsychological medicine · 2021
    Article
  17. Article
  18. Review
  19. Article
  20. Persistent persecutory delusions: The spirit, style and content of targeted treatment.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Daniel FreemanUniversity of Oxford,UK.
Jonathan BradleyUniversity of Oxford,UK.
Felicity WaiteUniversity of Oxford,UK.
Bryony SheavesUniversity of Oxford,UK.
Natalie DeWeeverUniversity of Oxford,UK.
Emilie BourkeUniversity of Oxford,UK.
Josephine McInerneyUniversity of Oxford,UK.
Nicole EvansUniversity of Oxford,UK.
Emma ČernisUniversity of Oxford,UK.
Rachel ListerUniversity of Oxford,UK.
Philippa GaretyKing's College London,Institute of Psychiatry, Psychology, and Neurosciences,UK.
Graham DunnUniversity of Manchester,UK.
University of Oxford · GBKing's College London · GBUniversity of Manchester · GB

Funding

Medical Research Council G0902308
6 · The paper itself

Abstract

backgroundMany patients do not respond adequately to current pharmacological or psychological treatments for psychosis. Persistent persecutory delusions are common in clinical services, and cause considerable patient distress and impairment. Our aim has been to build a new translational personalized treatment, with the potential for wide use, that leads to high rates of recovery in persistent persecutory delusions. We have been developing, and evaluating individually, brief modular interventions, each targeting a key causal factor identified from our cognitive model. These modules are now combined in "The Feeling Safe Programme".

aimsTo test the feasibility of a new translational modular treatment for persistent persecutory delusions and provide initial efficacy data.

method12 patients with persistent persecutory delusions in the context of non-affective psychosis were offered the 6-month Feeling Safe Programme. After assessment, patients chose from a personalized menu of treatment options. Four weekly baseline assessments were carried out, followed by monthly assessments. Recovery in the delusion was defined as conviction falling below 50% (greater doubt than certainty).

results11 patients completed the intervention. One patient withdrew before the first monthly assessment due to physical health problems. An average of 20 sessions (SD = 4.4) were received. Posttreatment, 7 out of 11 (64%) patients had recovery in their persistent delusions. Satisfaction ratings were high.

conclusionsThe Feeling Safe Programme is feasible to use and was associated with large clinical benefits. To our knowledge this is the first treatment report focused on delusion recovery. The treatment will be tested in a randomized controlled trial.

Indexed as

AdultAnxietyAnxiety DisordersCognitive Behavioral TherapyDelusionsEmotionsFeasibility StudiesFemaleHumansMaleMiddle AgedParanoid DisordersPilot ProjectsPsychiatric Status Rating ScalesPsychotic DisorderscognitiveDelusionsparanoiatreatment

Identifiers

PMID27044885
PMCPMC4988271
OpenAlexW2315125390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.